Thornburg Investment Management Inc Chemo Centryx, Inc. Transaction History

Thornburg Investment Management Inc

$7.17 Billion
Q3 2024

Shares

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 05, 2022	SELL	$15.36 - $27.51 $393,246 - $704,311	-25,602 Reduced 10.4%	220,675 $5.47 Million
Q1 2022 May 12, 2022	SELL	$22.22 - $39.12 $172,671 - $304,001	-7,771 Reduced 3.06%	246,277 $6.17 Million
Q4 2021 Feb 10, 2022	BUY	$18.38 - $40.5 $4.67 Million - $10.3 Million	254,048 New	254,048 $9.25 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thornburg Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Thornburg Investment Management Inc with notifications on news.